NCT00433641View on ClinicalTrials.gov

Weight Loss in Response to Sibutramine (MERIDIA) is Influenced by the Inherited Genes

PHASE4CompletedINTERVENTIONAL

Enrollment

181

Participants

Timeline

Start Date

July 31, 2006

Primary Completion Date

November 30, 2007

Study Completion Date

November 30, 2007

Conditions

Obesity

Interventions

DRUG

sibutramine

placebo

DRUG

sibutramine

oral 15 mg sibutramine once per day

DRUG

sibutramine

oral sibutramine 10 mg once per day

Trial Locations (1)

55905

Mayo Clinic, Rochester

Sponsors

Lead Sponsor

All Listed Sponsors

collaborator

National Institutes of Health (NIH)

NIH

lead

Mayo Clinic

OTHER

NCT00433641 - Weight Loss in Response to Sibutramine (MERIDIA) is Influenced by the Inherited Genes | Biotech Hunter | Biotech Hunter